{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-22-000005","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.153568+00:00","generated_at":"2026-06-27T20:01:55.024010+00:00","sec_items":["1.01","2.01","2.03","3.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"ICU Medical completes acquisition of Smiths Medical for $1.85B cash + stock","bullets":["Paid $1.85B cash and issued 2.5M shares of ICUI common stock; up to $100M additional contingent cash.","Entered into $2.2B Credit Facilities: $850M Term Loan A, $850M Term Loan B, $500M revolver.","Pro forma combined revenue approximately $2.5 billion; Smiths adds infusion, vascular, vital care products.","Seller (Smiths Group) gets board seat if owns >5% of ICUI; share transfer restricted for 6 months.","Company plans to provide full FY 2022 guidance on Q4 earnings call in late February."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-22-000005","json":"https://secwatch.observer/filing/0000883984-22-000005.json","markdown":"https://secwatch.observer/filing/0000883984-22-000005.md","text":"https://secwatch.observer/filing/0000883984-22-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/0000883984-22-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/icui-20220107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:01:55.024010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}